The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Astrazeneca Ab since 2014.
The trader's CIK number is 928966.
At the time of the last reporting, Astrazeneca Ab was the 10% Owner of Entasis Therapeutics Holdings Inc.. (stock ticker symbol ETTX).
Also see all insider trading activities at Entasis Therapeutics Holdings Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ALBO | 0 | $0 | 500,000 | $10,700,000 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | RGLS | 0 | $0 | 2,000,000 | $34,000,000 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ETTX | 246,666 | $3,699,990 | 0 | $0 | 0 | $0 |
1. Albireo Pharma, Inc. (ALBO)
2. Regulus Therapeutics Inc. (RGLS)
3. Entasis Therapeutics Holdings Inc. (ETTX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-12-01 | ALBO | Sale | 500,000 | 21.40 | 10,700,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-11-12 | RGLS | Sale | 2,000,000 | 17.00 | 34,000,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-09-28 | ETTX | Buy | 246,666 | 15.00 | 3,699,990 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Astrazeneca Ab (10% Owner of Entasis Therapeutics Holdings Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.